PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Pain D010146 64 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Arai I et al. Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice. 2007 Eur. J. Pharmacol. pmid:17141215
Chambers KT et al. PGJ2-stimulated beta-cell apoptosis is associated with prolonged UPR activation. 2007 Am. J. Physiol. Endocrinol. Metab. pmid:17148750
Liu JJ et al. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro. 2007 Ann. Hematol. pmid:17089125
Jin YR et al. Antiplatelet activity of hesperetin, a bioflavonoid, is mainly mediated by inhibition of PLC-gamma2 phosphorylation and cyclooxygenase-1 activity. 2007 Atherosclerosis pmid:17092506
Nicoll-Griffith DA et al. In vitro biotransformations of the prostaglandin D2 (DP) antagonist MK-0524 and synthesis of metabolites. 2007 Bioorg. Med. Chem. Lett. pmid:17095220
Hortobágyi L et al. Adaptation of the hypothalamic blood flow to chronic nitric oxide deficiency is independent of vasodilator prostanoids. 2007 Brain Res. pmid:17161389
Kang MA et al. Up-regulation of skeletal muscle LIM protein 1 gene by 25-hydroxycholesterol may mediate morphological changes of rat aortic smooth muscle cells. 2007 Life Sci. pmid:17161435
Sánchez-Gómez FJ et al. Direct evidence for the covalent modification of glutathione-S-transferase P1-1 by electrophilic prostaglandins: implications for enzyme inactivation and cell survival. 2007 Arch. Biochem. Biophys. pmid:17169324
Huang ZL et al. Prostaglandins and adenosine in the regulation of sleep and wakefulness. 2007 Curr Opin Pharmacol pmid:17129762
Kim HY and Kim HS Upregulation of MIP-2 (CXCL2) expression by 15-deoxy-Delta(12,14)-prostaglandin J(2) in mouse peritoneal macrophages. 2007 Immunol. Cell Biol. pmid:17130903
Jung SM et al. Reduction of urate crystal-induced inflammation by root extracts from traditional oriental medicinal plants: elevation of prostaglandin D2 levels. 2007 Arthritis Res. Ther. pmid:17612394
Sugimoto M et al. The anti-pruritic efficacy of TS-022, a prostanoid DP1 receptor agonist, is dependent on the endogenous prostaglandin D2 level in the skin of NC/Nga mice. 2007 Eur. J. Pharmacol. pmid:17328887
Suwaki N et al. Expression and potential role of peroxisome proliferator-activated receptor gamma in the placenta of diabetic pregnancy. 2007 Placenta pmid:16753211
Skogvall S et al. Effects of capsazepine on human small airway responsiveness unravel a novel class of bronchorelaxants. 2007 Pulm Pharmacol Ther pmid:16731017
Ruano D et al. Family-based and case-control studies reveal no association of lipocalin-type prostaglandin D2 synthase with schizophrenia. 2007 Am. J. Med. Genet. B Neuropsychiatr. Genet. pmid:17230501
Rehan VK et al. In utero nicotine exposure alters fetal rat lung alveolar type II cell proliferation, differentiation, and metabolism. 2007 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:17215434
Haack M et al. Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. 2007 Sleep pmid:17910386
Mathew B et al. Inhibitory kappaB kinase 2 activates airway epithelial cells to stimulate bone marrow macrophages. 2007 Am. J. Respir. Cell Mol. Biol. pmid:17204585
Gallant MA et al. Differential regulation of the signaling and trafficking of the two prostaglandin D2 receptors, prostanoid DP receptor and CRTH2. 2007 Eur. J. Pharmacol. pmid:17207480
Xue L et al. Inhibition of PI3K and calcineurin suppresses chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2)-dependent responses of Th2 lymphocytes to prostaglandin D(2). 2007 Biochem. Pharmacol. pmid:17196174
Jin YR et al. Antiplatelet effect of NQ12: a possible mechanism through the arachidonic acid cascade. 2007 J. Pharmacol. Sci. pmid:17951980
Van Hecken A et al. The effect of MK-0524, a prostaglandin D(2) receptor antagonist, on prostaglandin D (2)-induced nasal airway obstruction in healthy volunteers. 2007 Eur. J. Clin. Pharmacol. pmid:17200838
Moreira V et al. Bothrops jararaca and Crotalus durissus terrificus venoms elicit distinct responses regarding to production of prostaglandins E2 and D2, and expression of cyclooxygenases. 2007 Toxicon pmid:17241651
Liu M et al. Focal cerebral ischemia/reperfusion injury in mice induces hematopoietic prostaglandin D synthase in microglia and macrophages. 2007 Neuroscience pmid:17241746
Tinfo N and Komar C Potential role for peroxisome proliferator-activated receptor gamma in regulating luteal lifespan in the rat. 2007 Reproduction pmid:17244745
Lee JH et al. 15-deoxy-Delta 12,14-ProstaglandinJ2 regulates dedifferentiation through peroxisome proliferator-activated receptor-gamma-dependent pathway but not COX-2 expression in articular chondrocytes. 2007 J. Korean Med. Sci. pmid:17982241
Payne SG et al. The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptors. 2007 Blood pmid:17008548
Li SJ et al. [Effect of peroxisome proliferators-activated receptor gamma ligands on cytotrophoblast invasion in first trimester pregnancy]. 2007 Zhonghua Fu Chan Ke Za Zhi pmid:17983488
Porter DW et al. PGJ2 inhibition of LPS-induced inflammatory mediator expression from rat alveolar macrophages. 2007 J. Toxicol. Environ. Health Part A pmid:17966068
Nitta N et al. Quantitative analysis of eosinophil chemotaxis tracked using a novel optical device -- TAXIScan. 2007 J. Immunol. Methods pmid:17289072
Reyes-Martin P et al. Cyclooxygenase-independent inhibition of H2O2-induced cell death by S-ketoprofen in renal cells. 2007 Pharmacol. Res. pmid:17291778
Aldini G et al. Identification of actin as a 15-deoxy-Delta12,14-prostaglandin J2 target in neuroblastoma cells: mass spectrometric, computational, and functional approaches to investigate the effect on cytoskeletal derangement. 2007 Biochemistry pmid:17297918
Pettipher R et al. Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases. 2007 Nat Rev Drug Discov pmid:17396136
Gayarre J et al. Modification of proteins by cyclopentenone prostaglandins is differentially modulated by GSH in vitro. 2007 Ann. N. Y. Acad. Sci. pmid:17405918
Ito W et al. Hepatocyte growth factor attenuates eotaxin and PGD2-induced chemotaxis of human eosinophils. 2007 Allergy pmid:17362253
Yang WZ et al. [The effect of ligand of peroxisome proliferators-activated receptor gamma 15d-PGJ2 on the proliferation and activation of hepatic stellate cells]. 2007 Zhonghua Gan Zang Bing Za Zhi pmid:17362636
Wilhelm D et al. SOX9 regulates prostaglandin D synthase gene transcription in vivo to ensure testis development. 2007 J. Biol. Chem. pmid:17277314
Park JM et al. Hematopoietic prostaglandin D synthase suppresses intestinal adenomas in ApcMin/+ mice. 2007 Cancer Res. pmid:17283118
Hammad H et al. Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells. 2007 J. Exp. Med. pmid:17283205
Kim HJ et al. 15-deoxy-Delta12,14-prostaglandin J2 inhibits transcriptional activity of estrogen receptor-alpha via covalent modification of DNA-binding domain. 2007 Cancer Res. pmid:17363578
Yamada K et al. Nose-to-brain delivery of TS-002, prostaglandin D2 analogue. 2007 J Drug Target pmid:17365274
Fionda C et al. 15-deoxy-Delta12,14-prostaglandin J2 negatively regulates rankl gene expression in activated T lymphocytes: role of NF-kappaB and early growth response transcription factors. 2007 J. Immunol. pmid:17371958
Saleem S et al. PGD(2) DP1 receptor protects brain from ischemia-reperfusion injury. 2007 Eur. J. Neurosci. pmid:17573924
Wu L et al. Divergent effects of prostaglandin receptor signaling on neuronal survival. 2007 Neurosci. Lett. pmid:17574754
Hasegawa H et al. A novel natural compound, a cycloanthranilylproline derivative (Fuligocandin B), sensitizes leukemia cells to apoptosis induced by tumor necrosis factor related apoptosis-inducing ligand (TRAIL) through 15-deoxy-Delta 12, 14 prostaglandin J2 production. 2007 Blood pmid:17551094
Ueki S et al. Anti- and proinflammatory effects of 15-deoxy-delta-prostaglandin J2(15d-PGJ2) on human eosinophil functions. 2007 Int. Arch. Allergy Immunol. pmid:17541271
Chiba T et al. Possible novel receptor for PGD2 on human bronchial epithelial cells. 2007 Int. Arch. Allergy Immunol. pmid:17541272
Engdahl R et al. 15-Deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) mediates repression of TNF-alpha by decreasing levels of acetylated histone H3 and H4 at its promoter. 2007 Biochem. Biophys. Res. Commun. pmid:17532302
Lin MS et al. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer. 2007 J Dig Dis pmid:17532820
Futaki N et al. Role of prostaglandins on mechanical scratching-induced cutaneous barrier disruption in mice. 2007 Exp. Dermatol. pmid:17518991
Aschenbach JR et al. Functional characteristics of the porcine colonic epithelium following transportation stress and Salmonella infection. 2007 Scand. J. Gastroenterol. pmid:17505993
Wang XS et al. PGE suppresses excessive anti-IgE induced cysteinyl leucotrienes production in mast cells of patients with aspirin exacerbated respiratory disease. 2007 Allergy pmid:17508965
Monroy MA et al. THE PPARgamma ligand 15d-PGJ2 modulates macrophage activation after injury in a murine trauma model. 2007 Shock pmid:17510607
Zingarelli B et al. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt. 2007 Shock pmid:17589386
Vunta H et al. The anti-inflammatory effects of selenium are mediated through 15-deoxy-Delta12,14-prostaglandin J2 in macrophages. 2007 J. Biol. Chem. pmid:17439952
Taniguchi H et al. Prostaglandin D2 protects neonatal mouse brain from hypoxic ischemic injury. 2007 J. Neurosci. pmid:17442814
Zhang XC et al. Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators. 2007 J. Pharmacol. Exp. Ther. pmid:17483291
Fulzele SV et al. 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors. 2007 Anticancer Drugs pmid:17159504
Richman JG et al. Nicotinic acid receptor agonists differentially activate downstream effectors. 2007 J. Biol. Chem. pmid:17452318
Schütz TC et al. Effects of COX-2 inhibitor in temporomandibular joint acute inflammation. 2007 J. Dent. Res. pmid:17452571
Zhao X et al. Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages. 2007 Ann. Neurol. pmid:17457822
Berry A et al. IL-13 induces expression of CD36 in human monocytes through PPARgamma activation. 2007 Eur. J. Immunol. pmid:17458857
Takeda K et al. Neuroendocrine functions of melanocytes: beyond the skin-deep melanin maker. 2007 Tohoku J. Exp. Med. pmid:17347546
Mazid MA et al. Development of enzyme-linked immunosorbent assay for prostaglandin D2 using the stable isosteric analogue as a hapten mimic and its application. 2007 Prostaglandins Other Lipid Mediat. pmid:17481559
Lim HJ et al. 15d-PGJ2 stimulates HO-1 expression through p38 MAP kinase and Nrf-2 pathway in rat vascular smooth muscle cells. 2007 Toxicol. Appl. Pharmacol. pmid:17631927
Olmos G et al. Accumulation of hypoxia-inducible factor-1alpha through a novel electrophilic, thiol antioxidant-sensitive mechanism. 2007 Cell. Signal. pmid:17658243
Xiang Z et al. 15d-PGJ2 induces apoptosis of mouse oligodendrocyte precursor cells. 2007 J Neuroinflammation pmid:17634127
Ye Y et al. Activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2. 2007 Prostaglandins Other Lipid Mediat. pmid:17643887
Desmarais JA et al. The peroxisome proliferator-activated receptor gamma regulates trophoblast cell differentiation in mink (Mustela vison). 2007 Biol. Reprod. pmid:17615406
Nagai H [The role of lipid mediators in allergic diseases]. 2007 Arerugi pmid:17615500
Kaplan J et al. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells. 2007 Shock pmid:17621259
Pierzchalska M et al. Deficiency of cyclooxygenases transcripts in cultured primary bronchial epithelial cells of aspirin-sensitive asthmatics. 2007 J. Physiol. Pharmacol. pmid:17622692
Lin TH et al. PPARgamma inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats. 2007 Bone pmid:17669705
Fionda C et al. Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes. 2007 Mol. Pharmacol. pmid:17673570
Joo M et al. Induction and function of lipocalin prostaglandin D synthase in host immunity. 2007 J. Immunol. pmid:17675519
Satoh T [Cysteine-mediated signaling pathway by a novel electrophilic compound, NEPP11]. 2007 Seikagaku pmid:17319510
Chintalgattu V et al. PPAR-gamma agonists induce the expression of VEGF and its receptors in cultured cardiac myofibroblasts. 2007 Cardiovasc. Res. pmid:17320065
Fournier T et al. Involvement of PPARgamma in human trophoblast invasion. 2007 Placenta pmid:17321592
Rajakariar R et al. Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2. 2007 Proc. Natl. Acad. Sci. U.S.A. pmid:18077391
Moulin D et al. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. 2007 Cytokine pmid:18023358
Haworth O and Buckley CD Resolving the problem of persistence in the switch from acute to chronic inflammation. 2007 Proc. Natl. Acad. Sci. U.S.A. pmid:18093938
Wang LH et al. Inhibition of adhesive interaction between multiple myeloma and bone marrow stromal cells by PPARgamma cross talk with NF-kappaB and C/EBP. 2007 Blood pmid:17785586
Han H et al. 15-Deoxy-delta 12,14-prostaglandin J2 (15d-PGJ 2) sensitizes human leukemic HL-60 cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through Akt downregulation. 2007 Apoptosis pmid:17786557
Yoon EK et al. ERK-1/-2 and p38 kinase oppositely regulate 15-deoxy-delta(12,14)-prostaglandinJ(2)-Induced PPAR-gamma activation that mediates dedifferentiation but not cyclooxygenase-2 expression in articular chondrocytes. 2007 J. Korean Med. Sci. pmid:18162716
Cao LQ et al. [15-deoxy-Delta(12,14)-prostaglandin J(2) induces anoikis of hepatocellular carcinoma cells: an in vitro experiment]. 2007 Zhonghua Yi Xue Za Zhi pmid:18261336
Siddhivarn C et al. Mechanical loading and delta12prostaglandin J2 induce bone morphogenetic protein-2, peroxisome proliferator-activated receptor gamma-1, and bone nodule formation in an osteoblastic cell line. 2007 J. Periodont. Res. pmid:17760815
Wu P et al. Inflammation pro-resolving potential of 3,4-dihydroxyacetophenone through 15-deoxy-delta12,14-prostaglandin J2 in murine macrophages. 2007 Int. Immunopharmacol. pmid:17761349
Saito Y et al. Protective effects of 15-deoxy-Delta12,14-prostaglandin J2 against glutamate-induced cell death in primary cortical neuron cultures: induction of adaptive response and enhancement of cell tolerance primarily through up-regulation of cellular glutathione. 2007 J. Neurochem. pmid:17697048
Iikura M et al. IL-33 can promote survival, adhesion and cytokine production in human mast cells. 2007 Lab. Invest. pmid:17700564
Kondoh K et al. Inhibition of estrogen receptor beta-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced apoptosis in cancer cells. 2007 Exp. Cell Res. pmid:17706193
Richard CL et al. 15-Deoxy-delta(12,14)-prostaglandin J(2) down-regulates CXCR4 on carcinoma cells through PPARgamma- and NFkappaB-mediated pathways. 2007 Exp. Cell Res. pmid:17707368
Chen Y et al. Prostaglandin D2 suppresses human NK cell function via signaling through D prostanoid receptor. 2007 J. Immunol. pmid:17709490
Li Y et al. Prediction of the 3D structure and dynamics of human DP G-protein coupled receptor bound to an agonist and an antagonist. 2007 J. Am. Chem. Soc. pmid:17691773
Parameswaran K et al. Modulation of human airway smooth muscle migration by lipid mediators and Th-2 cytokines. 2007 Am. J. Respir. Cell Mol. Biol. pmid:17431098
Rehan VK et al. A paradoxical temporal response of the PTHrP/PPARgamma signaling pathway to lipopolysaccharide in an in vitro model of the developing rat lung. 2007 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:17435078
Vinall SL et al. A paracrine role for chemoattractant receptor-homologous molecule expressed on T helper type 2 cells (CRTH2) in mediating chemotactic activation of CRTH2+ CD4+ T helper type 2 lymphocytes. 2007 Immunology pmid:17437532
Cossette C et al. Agonist and antagonist effects of 15R-prostaglandin (PG) D2 and 11-methylene-PGD2 on human eosinophils and basophils. 2007 J. Pharmacol. Exp. Ther. pmid:17041009
Sandig H et al. Contrary prostaglandins: the opposing roles of PGD2 and its metabolites in leukocyte function. 2007 J. Leukoc. Biol. pmid:17043246
Kamagata C et al. 15-deoxy-Delta(12,14)-prostaglandin J2 inhibits G2-M phase progression in human breast cancer cells via the down-regulation of cyclin B1 and survivin expression. 2007 Breast Cancer Res. Treat. pmid:17028981
García-Bueno B et al. Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats. 2007 Neuropsychopharmacology pmid:17119541